JOHN BRODERICK-CANTWELL: Open Payments
NPI 1760493365 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 19 payments from 10 companies in 2025. Trend: 2023 $13 · 2024 $531 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 1 | $30 |
| Almatica Pharma LLC | 2 | $30 |
| Alkermes, Inc. | 1 | $24 |
| Corium, LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, REXULTI, TRINTELLIX, Qelbree, LOREEV XR, ARISTADA, Azstarys.
Industry payments across AL — which companies pay providers there.
